DMSFX Mutual Fund

NAV$10.27

Fund Essentials - as of Nov 30, 2025

Net Assets
$533M
Expense Ratio
1.32%
Dividend Yield (Current)
3.51%
Holdings
144
Inception Date
Mar 20, 2017
Fund Family
Destinations Funds
Investment Style
••••••••••
Asset Class
••••••••••
Legal Structure
••••••••••
Dividend Frequency
Quarterly

Performance

YTD+0.63%
1 Year+3.63%
3 Year+4.91%
5 Year+3.68%

Asset Allocation

Stocks: 22.76%
Bonds: 58.37%
Cash: 0.37%
Other: 18.50%

Top Holdings

View All →
TickerNameWeight
MUV2:SGMuenchener Rungs Ghft in Mnhn AG13.26%
-Barings Clo Ltd 2021-I Ser 2021-1A Cl B V/R Regd 144A P/P 7.039830002.46%
XENEXenon Pharmaceuticals Inc2.03%
VST V7 PERP 144AVistra Corp Regd V/R /Perp/ 144A P/P 7.000000001.99%
CRNXCrinetics Pharmaceuticals Inc Com1.72%
Top 10 Concentration: 29.02%Report Date: Nov 30, 2025
Download all 144 holdings for DMSFX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
3.51%
Frequency
Quarterly
Latest Distribution
$0.17
-

Peer Comparison

Benchmark
••••••••••
Outperforming by ••••%
Ranked #••• of •,••• funds
This Mutual Fund
+••.••%
Peer Avg
+••.••%
Premium Feature
Sign in to unlock peer comparison, category rankings and more

DMSFX Mutual Fund Overview

DMSFX Mutual Fund (Destinations Multi Strategy Alternatives Fund Class I) is managed by Destinations Funds with $532.5M in net assets. DMSFX expense ratio is 1.32%, holding 144 positions across sectors including Other, Unknown, Financials. Inception date: 2017-03-20.

DMSFX performance shows a YTD return of 0.63%. The 1-year return is 3.63% and the 5-year return is 3.68%. DMSFX dividend yield stands at 3.51%, paid quarterly.

DMSFX top holdings include Muenchener Rungs Ghft in Mnhn AG (13.3%), Barings Clo Ltd 2021-I Ser 2021-1A Cl B V/R Regd 144A P/P 7.03983000 (2.5%), Xenon Pharmaceuticals Inc (2.0%), Vistra Corp Regd V/R /Perp/ 144A P/P 7.00000000 (2.0%), Crinetics Pharmaceuticals Inc Com (1.7%). View all DMSFX holdings, sector breakdown, or dividend history.

DMSFX can be compared against other funds using the overlap calculator or side-by-side comparison tool. DMSFX alternatives are available via the screener, along with tax-loss harvesting opportunities.